Table 2. Gradual loss of nuclear ESRP1 expression is associated with CRC progression.
Tissue type | Number of cases | ESRP1 expression (%) | p-value | |
---|---|---|---|---|
Average | Median | |||
Normal | 26 | 75 | 75 | <0.0001 |
Adenoma | 42 | 56.8 | 60 | |
Carcinoma | 185 | 26.5 | 15 | |
Lymph node metastasis | 68 | 9.1 | 0 |
Statistics: Kruskal-Wallis test was performed. This table relates to Figure 6.